EGLN1 and colorectal carcinoma: Our study is the first to investigate the methylation status of the promoter regulatory regions of PHD1, PHD2, PHD3 and FIH in primary cancerous tissue from patients with CRC, and HCT116, DLD-1 CRC cell lines.